Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Read about user experiences with no fee travel points cards. Gain insights to enhance your travel rewards journey!
17,260 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
As Nasdaq volatility surges amid broader market jitters, one sub-$20 tech stock with a near-monopoly in a niche data ...
Regulators and lenders are accelerating a shift toward scale in mortgage services. The change threatens many smaller ...
Windfalls from settlements and inheritances are surging in 2026, but experts warn these gains often fade within a few...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
Walmart CFO cites a drop in average gas fills as a sign of consumer stress, highlighting how higher fuel costs are sh...
When a stock starts gaining again today, traders watch for real catalysts behind the move. This article breaks down w...
When a major institutional investor trims a fund like COMT, the move can ripple through risk, liquidity, and prices. ...
As AI fuels energy needs, NuScale’s small modular reactors offer a faster, scalable path to cleaner power. This guide...
As Kevin Warsh takes the helm at the Federal Reserve, XRP and the Ripple ecosystem face a fresh policy backdrop. Gemi...
As AI accelerates, the stock narrative centers on NVIDIA, AMD, and Broadcom. This guide breaks down why each could de...
As SpaceX moves toward a historic public listing, Antonio Gracias could see his private stake surge into the tens of ...